TCA
VRNA

Transcend Capital Advisors’s Verona Pharma VRNA Stock Holding History

Transcend Capital Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$287K Buy
+3,035
New +$287K 0.02% 471
2025
Q1 		– Sell
-4,835
Closed -$225K – 637
2024
Q4 		$225K Buy
+4,835
New +$225K 0.02% 510